Dynamic Balance of Histone H3 Methylation: Regulatory Mechanisms and Therapeutic Prospects in RA Immune Dysregulation and Bone Metabolism Imbalance
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/5642138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Immunology Research, online erschienen am 07.08.2026. Verfasst von Shili Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou Province, China, gzu.edu.cn. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Histones, Bone and Bones. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guizhou University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Objective
To clarify the regulatory mechanisms of the dynamic balance of histone H3 methylation in rheumatoid arthritis (RA) immune dysregulation and bone metabolism imbalance, and to explore related therapeutic approaches.
Methods
We systematically reviewed the roles of key histone H3 methylation sites, including H3K4me3, H3K9me3, and H3K27me3, in RA immune cell activation, inflammatory signaling pathway regulation, and bone cell differentiation. We analyzed the core functions of these sites in the cross‐regulation of “immune dysregulation—bone metabolism imbalance” and discussed therapeutic strategies targeting this methylation balance.
Results
Accumulating preclinical evidence indicates that the dynamic balance of histone H3 methylation may regulate RA immune cell differentiation imbalance, excessive activation of inflammatory signaling pathways, and the imbalance state where bone resorption exceeds bone formation by modulating the activities of methyltransferases and demethylases. This balance appears to be a key mechanistic link connecting RA immune dysregulation and bone metabolism imbalance. Agents targeting this balance (such as EZH2 inhibitors and Janus kinase [JAK] inhibitors) have shown promising preclinical potential for dual anti‐inflammatory and bone‐protective effects.
Conclusion
The dynamic balance of histone H3 methylation emerges as a potential core regulatory hub in the pathological process of RA based on preclinical studies, providing theoretical support for precise diagnosis and treatment of RA. Related targeting strategies may become a new direction to break through the limitations of existing treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou Province, China, gzu.edu.cn.
ORCID-Profile: Shili Yang, Huaiquan Liu, Haiyang Kou, Lingyan Lai, Bo Chen
Förderung
- National Natural Science Foundation of China
- Guizhou University of Traditional Chinese Medicine
Zitieren
APA
Yang, S., Liu, H., Kou, H., Lai, L., Zhang, X., Xu, Y., Sun, Y., & Chen, B. (2026). Dynamic Balance of Histone H3 Methylation: Regulatory Mechanisms and Therapeutic Prospects in RA Immune Dysregulation and Bone Metabolism Imbalance. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/5642138
Vancouver
Yang S, Liu H, Kou H, Lai L, Zhang X, Xu Y, et al. Dynamic Balance of Histone H3 Methylation: Regulatory Mechanisms and Therapeutic Prospects in RA Immune Dysregulation and Bone Metabolism Imbalance. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/5642138
BibTeX
@article{Yang2026,
author = {Yang, Shili and Liu, Huaiquan and Kou, Haiyang and Lai, Lingyan and Zhang, Xinyan and Xu, Yunling and Sun, Yu and Chen, Bo},
title = {Dynamic Balance of Histone H3 Methylation: Regulatory Mechanisms and Therapeutic Prospects in RA Immune Dysregulation and Bone Metabolism Imbalance},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/5642138}
}
EUVIMED